Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/16/1991 | WO1991006643A1 Process for conducting site-directed mutagenesis |
05/16/1991 | WO1991006639A1 Recombinant production of lactoperoxidase |
05/16/1991 | WO1991006632A1 Inhibition of padgem-mediated cell binding |
05/16/1991 | WO1991006629A1 Oligonucleotide analogs with novel linkages |
05/16/1991 | WO1991006626A2 Triple helix formation in oligonucleotide therapy |
05/16/1991 | WO1991006574A1 A process for preparing peroxycarboxylic acids |
05/16/1991 | WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
05/16/1991 | WO1991006570A1 HYBRID Fc RECEPTOR MOLECULES |
05/16/1991 | WO1991006568A1 High molecular weight human angiogenic factors |
05/16/1991 | WO1991006567A1 M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them |
05/16/1991 | WO1991006558A1 Process for peptide synthesis and vehicles therefor |
05/16/1991 | WO1991006557A1 A cDNA ENCODING THE LONG ISOFORM OF THE D2 DOPAMINE RECEPTOR |
05/16/1991 | WO1991006556A1 2' modified oligonucleotides |
05/16/1991 | WO1991006319A1 Methods and compositions for promoting immunopotentiation |
05/16/1991 | WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
05/16/1991 | WO1991006309A1 Method of in vivo delivery of functioning foreign genes |
05/16/1991 | WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast |
05/16/1991 | CA2072977A1 Site-specific modification of the candida tropicalis genome |
05/16/1991 | CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
05/16/1991 | CA2071892A1 Process for conducting site-directed mutagenesis |
05/16/1991 | CA2071478A1 Methods and compositions for promoting immunopotentiation |
05/16/1991 | CA2068649A1 Methods for detecting human leukemias |
05/16/1991 | CA2045184A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use |
05/15/1991 | EP0427529A1 Larvicidal lectins and plant insect resistance based thereon |
05/15/1991 | EP0427405A1 Yeasts and their use in astaxanthin production |
05/15/1991 | EP0427385A1 Gene expression unit comprising the promoter and the terminator as well as the gene of alkaline protease |
05/15/1991 | EP0427296A1 Insulin precursors |
05/15/1991 | EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them |
05/15/1991 | EP0427035A1 Protein overexpression in recombinant host cells |
05/15/1991 | EP0427014A1 Plasmid |
05/15/1991 | EP0426860A1 New protease inhibitor and production thereof |
05/15/1991 | EP0426843A1 Nucleic acid probes for the detection of neisseria gonorrhoeae. |
05/15/1991 | EP0426840A1 Improved baculovirus expression vectors |
05/15/1991 | EP0426837A1 Nucleic acid probes for the detection of staphylococcus aureus. |
05/15/1991 | EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
05/15/1991 | EP0426756A1 Rna and dna amplification techniques |
05/15/1991 | EP0426744A1 High efficiency translation of polycistronic messages in eucaryotic cells |
05/15/1991 | CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/15/1991 | CN1051302A Biologically active proteins and method for their prodn. |
05/15/1991 | CA2029714A1 Antiidiotypic monoclonal antibodies |
05/14/1991 | WO1991007664A1 Diagnostic proteins to test for more than one antibody |
05/14/1991 | WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | WO1991007493A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | WO1991007492A1 Monoclonal antibodies |
05/14/1991 | WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
05/14/1991 | US5015582 Isolated phenylalanine dehydrogenase gene and process for production of phenylalanine dehydrogenase |
05/14/1991 | US5015581 Method for producing the Hinc II restriction endonuclease and methylase |
05/14/1991 | US5015580 Genetic Engineering Using Gene Coated Gold Particles |
05/14/1991 | US5015577 Genetic engineering, recombitant vectors |
05/14/1991 | US5015575 Production of polypeptides having insulin activity, yeast secretions |
05/14/1991 | US5015574 Genetic engineering |
05/14/1991 | US5015573 DNA vectors and their use in recombinant DNA technology |
05/14/1991 | US5015568 Quantitative analysis of antibodies and antigens for b-cells |
05/14/1991 | CA2068325A1 Rrna specific oligonucleotides |
05/14/1991 | CA2045524A1 Diagnostic proteins to test for more than one antibody |
05/14/1991 | CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA1284119C Expression method using recombinant bombyx mori nuclear polyhedrosis virus dna |
05/08/1991 | WO1991006649A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment |
05/08/1991 | WO1991006305A1 Oligomeric immunoglobulins |
05/08/1991 | EP0426656A2 Process for the preparation of 2-arylpropionic acids |
05/08/1991 | EP0426641A2 Promoter for transgenic plants |
05/08/1991 | EP0426521A1 Use of interleukine 2 for the treatment of leukemias |
05/08/1991 | EP0426455A2 Cloning vector plasmid, vector-primer derived therefrom and preparation method of cDNA bank using the same |
05/08/1991 | EP0426195A1 Improvements in or relating to organic compounds |
05/08/1991 | EP0426059A1 Promoter regions of the genes which code for the pilinic subunits fim2, fim3 and fimx of Bordetella pertussis and their use for the expression of genes which code for a protein of interest |
05/08/1991 | EP0425995A2 Use of conserved oligonucleotide primers to amplify human papillomavirus DNA sequences |
05/08/1991 | EP0425661A1 A new method for tapping the immunological repertoire |
05/08/1991 | EP0425616A1 Use of animal-derived anti-microbial peptides for control of plant pathogens |
05/08/1991 | EP0425597A1 A tryptamine producing tryptophan decarboxylase gene of plant origin |
05/08/1991 | EP0425580A1 Synthetic hiv protease gene and method for its expression |
05/08/1991 | EP0425563A1 Process for amplifying and detecting nucleic acid sequences. |
05/08/1991 | EP0425549A1 Novel proteins, dna coding for said proteins, and their use |
05/08/1991 | EP0425536A1 Nonglycosylated human interleukin-3 compositions |
05/08/1991 | EP0425482A1 Human insulin analogs and preparations containing them. |
05/08/1991 | CN1051199A Modified biological material |
05/08/1991 | CN1051198A Recombinant growth factors |
05/08/1991 | CA2045150A1 Oligomeric immunoglobulins |
05/08/1991 | CA2044578A1 Mouse antibody v region gene fragments and method of chimeric antibody preparation using said gene fragments |
05/08/1991 | CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them |
05/07/1991 | US5013830 Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers |
05/07/1991 | US5013824 Human interleukin-4 peptides and conjugates thereof |
05/07/1991 | US5013662 Bacterial methionine n-terminal peptidase |
05/07/1991 | US5013660 Method of implanting living cells with a foreign substance |
05/07/1991 | US5013659 Hybrid to resist sulfonylureas |
05/07/1991 | US5013658 Transposon tagging of genes in transformed plants |
05/07/1991 | US5013657 Subtilisin mutations |
05/07/1991 | US5013653 Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
05/07/1991 | US5013652 DNA sequence for expression of polypeptides |
05/07/1991 | US5013650 Increased fermentation yield of expressed protein |
05/07/1991 | US5013649 Proteins; bone disorders |
05/04/1991 | WO1991006317A1 Cross-protective salmonella vaccines |
05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/04/1991 | CA2072633A1 Cross-protective salmonella vaccines |
05/04/1991 | CA2029241A1 Inhibitors of tospovirus |
05/04/1991 | CA2029146A1 Promoter regions of the genes which code for the pilinic subunits fim2, fim3 and fimx of bordetella pertussis and their use for the expression of genes which code for a protein ofinterest |
05/04/1991 | CA2029126A1 Use of conserved oligonucleotide primers to amplify human papillomavirus dna sequences |
05/02/1991 | WO1991006009A1 N-acetylmuramidase m1 |
05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |